| Mrs Nicole Catherine Kratochvil, PA-C | |
|
812 N 22nd St, Blair, NE 68008-1128 | |
| (402) 426-4611 | |
| (402) 426-4642 |
| Full Name | Mrs Nicole Catherine Kratochvil |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 13 Years |
| Location | 812 N 22nd St, Blair, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477841898 | NPI | - | NPPES |
| 2099 | Other | NE | NE STATE LICENSE |
| 4901 | Other | AZ | AZ STATE PA LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 4901 (Arizona) | Secondary |
| 363AM0700X | Physician Assistant - Medical | 2099 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Community Hospital Mch & Health System | Blair, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Community Hospital Corporation | 0749190775 | 19 |
News Archive
Prostate cancer screening has little benefit for men aged 75 and older, yet over three years, the Medicare fee-for-service program spent $447 million annually on PSA-based screenings-one-third of which was for men in the over 75 age group, according to study by researchers at the Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the U.S. Food and Drug Administration has approved the Company's two abbreviated New Drug Applications to market granisetron hydrochloride injection, USP (granisetron), an antiemetic used to prevent nausea and vomiting caused by chemotherapy.
Some physicians are prescribing opioids such as OxyContin 55 times as often as others, according to a new study led by St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES). The study found most opioid-related deaths occur among patients treated by physicians who frequently prescribe opioids, suggesting doctors who prescribe a lot of opioids may not be doing so safely.
Van Andel Research Institute researchers have found a way to reverse resistance to sunitinib, a treatment that is currently the first line of defense against clear cell renal cell carcinoma (ccRCC), a deadly form of kidney cancer. Most patients who show a positive response to sunitinib develop a resistance to the drug after one year of treatment.
The AARP endorsed the measure, introduced in both the House and Senate, which in 2014 would require Medigap insurers to spend 85 percent of every premium dollar in the group market on medical care.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Nicole Catherine Kratochvil, PA-C 812 N 22nd St, Blair, NE 68008-1128 Ph: (402) 426-4611 | Mrs Nicole Catherine Kratochvil, PA-C 812 N 22nd St, Blair, NE 68008-1128 Ph: (402) 426-4611 |
News Archive
Prostate cancer screening has little benefit for men aged 75 and older, yet over three years, the Medicare fee-for-service program spent $447 million annually on PSA-based screenings-one-third of which was for men in the over 75 age group, according to study by researchers at the Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the U.S. Food and Drug Administration has approved the Company's two abbreviated New Drug Applications to market granisetron hydrochloride injection, USP (granisetron), an antiemetic used to prevent nausea and vomiting caused by chemotherapy.
Some physicians are prescribing opioids such as OxyContin 55 times as often as others, according to a new study led by St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES). The study found most opioid-related deaths occur among patients treated by physicians who frequently prescribe opioids, suggesting doctors who prescribe a lot of opioids may not be doing so safely.
Van Andel Research Institute researchers have found a way to reverse resistance to sunitinib, a treatment that is currently the first line of defense against clear cell renal cell carcinoma (ccRCC), a deadly form of kidney cancer. Most patients who show a positive response to sunitinib develop a resistance to the drug after one year of treatment.
The AARP endorsed the measure, introduced in both the House and Senate, which in 2014 would require Medigap insurers to spend 85 percent of every premium dollar in the group market on medical care.
› Verified 3 days ago
Mark P Christiansen, PAC Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 812 N 22nd St, Blair, NE 68008 Phone: 402-426-4611 Fax: 402-426-4642 | |
Lynda D Arnold, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 812 N 22nd St, Blair, NE 68008 Phone: 402-426-4611 Fax: 402-426-4642 | |
Susan Ryan, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 718 S 19th St, Blair, NE 68008 Phone: 402-426-5171 | |
Bruce L Town, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 812 N 22nd St, Blair, NE 68008 Phone: 402-426-4611 Fax: 402-426-4642 | |
Cameron J Ourada, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 810 N 22nd St, Blair, NE 68008 Phone: 402-426-1629 Fax: 402-426-1297 | |
Matthew D Garris, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 407 S. 19th St, Blair, NE 68008 Phone: 402-533-2223 Fax: 531-301-6272 |